The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.102%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,960.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Sterling Rebound, Ex-Divs Send UK Stocks Lower

Thu, 16th Feb 2017 17:05

LONDON (Alliance News) - UK stocks retreated from yesterday's gains to end lower on Thursday, as the FTSE 100 was dragged down by a number of blue-chip stocks going ex-dividend and a recovery in sterling.

"Equity markets are under the cosh this morning from a hat trick of pressures. A dollar sell-off has produced currency hindrance by way of sterling and euro strength to hinder the internationally exposed. Some large-caps have gone ex-dividend. Miners are failing to see a weak dollar benefit in base metals prices," said Mike van Dulken, head of research at Accendo Markets.

The FTSE 100 index ended down 0.3%, or 24.49 points, at 7,277.92. The FTSE 250 closed down 0.7%, or 121.48 points, at 18,705.72, and the AIM All-Share finished down 0.28 point, at 906.46.

The BATS UK 100 ended down 0.5%, at 12,312.98, the BATS 250 closed down 0.6% at 17,025.66, and the BATS Small Companies ended down 0.2% at 10,960.29.

The CAC 40 index in Paris ended down 0.5%, while the DAX 30 in Frankfurt ended down 0.3%.

"Is today the day when investors look at the gains seen since the November 9 and make a calculation as to how much is priced in relative to what President Trump can deliver?" said CMC Market analyst Michael Hewson.

"The US President has promised financial markets something phenomenal in the next couple of weeks; however the big question is will he be able to deliver what the market is pricing in?" said Hewson. "This may help explain why markets in Europe are starting to slide back, with the DAX slipping back from its highs seen earlier this year, above 11,800."

"This would seem an eminently sensible strategy after several days of decent gains which have largely been premised on an improving economic outlook. Even the FTSE 250, which has risen for seven days in a row, has slid lower, while the FTSE 100 appears unable to sustain last nights close above the 7,300 level, as a number of stocks go ex-dividend," Hewson added.

Anchor bottler Coca-Cola HBC led the blue-chip gainers for most of Thursday after hiking its annual dividend payment for 2016 by 10% to EUR0.44 per share following a rise in pretax profit to EUR266.9 million from EUR192.4 million, driven by a reduction in costs. The stock ended as the best performer, up 4.8%.

Shire was the second best performer in FTSE 100 after reporting well-received annual results at midday, as it bolstered confidence in its immediate prospects and growth plans and demonstrated the strength of its major US acquisition Baxalta.

For 2016, Shire reported an operating income of USD962.9 million, down from USD1.42 billion the prior year, as a result of integration and acquisition costs. But Baxalta also drove a jump in product sales to USD10.89 billion from USD6.10 billion, and Shire guided to a further significant lift in product sales in 2017.

Shire closed up 3.5%. Blue-chip peers GlaxoSmithKline, Hikma Pharmaceuticals and Mediclinic closed up 1.8%, 1.1% and 0.9%, respectively.

Fellow FTSE 100 drugmaker Astrazeneca however ended as the worst performer in the index, down 3.1%, as one of many UK stocks to go ex-dividend on Thursday, meaning new investors no longer qualify for previously declared dividend payments.

London's two oil giants also went ex-dividend and ended among the worst blue-chip performers, compounded by a slide in oil prices. Royal Dutch Shell 'A' shares closed down 1.6%, 'B' shares ended 1.8% lower, and BP shares closed down 1.6%.

Brent traded at USD55.33 a barrel at the London equities close on Thursday, dipping from USD55.75 a barrel at the same time Wednesday. Meanwhile, gold went the other way and traded at USD1,240.80 at the London close, rising from USD1,228.92 an ounce on Wednesday.

Lancashire Holdings was comfortably the biggest gainer in the FTSE 250 on Thursday, closing 8.7% higher. Numis and Shore Capital were positive on the company, after the specialist insurer reported "excellent" results "materially ahead" of consensus, despite profit and premiums written dropping in 2016 amid pressure on prices.

Cobham suffered heavily on Thursday after issuing yet another profit warning for 2016 and providing a bleak outlook for the coming year, as the aerospace firm said delivering a performance in 2017 in line with 2016 may prove "challenging". Shares closed down 13.9%, the worst performer in the mid-cap index.

Cobham had already warned on its 2016 results in January, its third downgrade for the year, and it added a fourth warning on Thursday. Cobham said underlying trading profit for 2016 will be around GBP225.0 million, compared to the GBP245.0 million to which it had already cut its guidance back in January.

UK power generator Drax Group was also one of the worst performers in the FTSE 250, closing down 5.8%, after placing its dividend policy under review as its 2016 payout more than halved as a result of a similar fall in underlying earnings, caused by a tough commodity market and the loss of renewable subsidies.

Stocks in New York were pointing lower on Thursday after achieving strong gains on Wednesday on the back of hawkish comments from US Federal Reserve Chair Janet Yellen and positive US economic data. The DJIA was trading 0.2% lower, while the S&P 500 index and NASDAQ Composite were both trading down 0.4%.

The euro was quoted at USD1.0668 at the London close, compared to USD1.0590 at the same time on Wednesday. Sterling recovered from its decline against the dollar on Wednesday, when it traded at USD1.2462 at the London equities close, and was trading at USD1.2493 at the close on Thursday.

"Despite a continued improvement in US economic data the US dollar has struggled to make any further gains today, sliding across the board," said CMC's Hewson.

"Why this US dollar weakness is happening now is difficult to pinpoint, however Fed vice Chair Stanley Fischer's comments to Bloomberg this morning were that the Fed was moving closer to the central bank's target rate for inflation, and as such the time was getting closer to the optimum level for another hike," CMC's Hewson added.

"While these comments were broadly in line with Janet Yellen's they still don't chime with the prospect of a move in March, and that may well be behind today's US dollar weakness," Hewson said.

The economic calendar on Friday starts with the release of Eurozone current accounts by the European Central Bank at 0900 GMT, followed by UK retail sales at 0930 GMT. Eurozone construction output is at 1000 GMT and the Baker Hughes UK oil rig count comes late in the day at 1800 GMT.

Friday's UK corporate calendar sees full year results from warehouse property investor Segro, plastic and fibre product provider Essentra, building materials firm Kingspan Group, Temple Bar Investment Trust, and Millennium & Copthorne Hotels.

By Joshua Warner; joshuawarner@alliancenews.com; @JoshAlliance

Copyright 2017 Alliance News Limited. All Rights Reserved. 

More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.